NCT00045877已完成2 期
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 117
研究概览
简要总结
The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have previously failed Rituxan treatments.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (117)
Loading locations...
相似试验
已完成
2 期
Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.Lymphoma, Non-HodgkinNCT00045864Chiron Corporation
Unknown
2 期
Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant MelanomaMalignant Melanoma of Skin Stage IIIMetastatic MelanomaNCT02142335California Cancer Assocaties for Research & Excellence17
已完成
1 期
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast CancerBreast CarcinomaHER-2 Positive Breast CancerMetastatic Breast CancerNCT02066532Dawn L. Hershman32
已完成
2 期
A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin LymphomaRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasNCT02086175Dana-Farber Cancer Institute25
Unknown
2 期
Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell LymphomaLymphoma, B-CellNCT04246359Huiqiang Huang52